
==== Front
Rev Soc Bras Med Trop
Rev Soc Bras Med Trop
rsbmt
Revista da Sociedade Brasileira de Medicina Tropical
0037-8682
1678-9849
Sociedade Brasileira de Medicina Tropical - SBMT

00806
10.1590/0037-8682-0344-2023
Case Report
Case Reports: Presumable tuberculous mastitis-like
https://orcid.org/0000-0002-8292-3153
Tavares Michel de Araujo 1 2 Concept and design Acquisition analysis or interpretation of data Drafting of the manuscript Statistical analysis had full access to all the data in the study take responsibility for the integrity of the data the accuracy of the data analysis Critical revision of the manuscript for important intellectual content
https://orcid.org/0000-0002-7140-7145
dos Santos Marcelo Cordeiro 3 4 Acquisition, analysis or interpretation of data Critical revision of the manuscript for important intellectual content
https://orcid.org/0000-0002-9534-7407
Monteiro Vinicius da Silva 5 Acquisition analysis or interpretation of data Critical revision of the manuscript for important intellectual content
https://orcid.org/0000-0001-8726-3994
Baia-da-Silva Djane 3 4 6 7 Critical revision of the manuscript for important intellectual content
https://orcid.org/0000-0003-3374-9985
de Lacerda Marcus Vinícius Guimarães 3 7 Acquisition analysis or interpretation of data Drafting of the manuscript Critical revision of the manuscript for important intellectual content
https://orcid.org/0000-0003-2014-9016
Vieira René Aloisio da Costa 1 Concept and design Acquisition analysis or interpretation of data Statistical analysis had full access to all the data in the study take responsibility for the integrity of the data the accuracy of the data analysis
1 Universidade Estadual Paulista “Júlio de Mesquita Filho”, Faculdade de Medicina de Botucatu, Programa de Pós-Graduação em Tocoginecologia, Botucatu, SP, Brasil.
2 Universidade Federal do Amazonas, Faculdade de Medicina, Departamento de Clínica Médica, Manaus, AM, Brasil.
3 Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, AM, Brasil.
4 Universidade do Estado do Amazonas, Programa de Pós-Graduação em Medicina Tropical, Manaus, AM, Brasil.
5 Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Serviço de Assistência Especializada, Manaus, AM, Brasil.
6 Universidade Nilton Lins, Manaus, AM, Brasil.
7 Fundação Oswaldo Cruz/Instituto Leônidas & Maria Deane, Instituto de Pesquisa Clínica Carlos Borborema, Manaus, AM, Brasil.
✉ Michel de Araujo Tavares. e-mail: micheltavares@hotmail.com
Conflict of Interest: The authors declare no conflict of interest.

02 9 2024
2024
57 e00806-202407 8 2023
17 11 2023
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
ABSTRACT

Tuberculous mastitis (TM) is a rare cause of breast disease. The test sensitivity for TM is low and sometimes characterized by idiopathic granulomatous mastitis. Both have different treatments; however, many patients are treated with presumptive TM (P-TM). We present fifteen women with confirmed TM or P-TM. We found 4% (5/124) of TM and 8% (10/124) of P-TM, grouped according to their diagnosis, with no differences between them, except for follow-up and treatment time. P-TM is an entity that must be considered based on clinical and radiological suspicion and is associated with presumptive pathological data.

Keywords:

Granulomatous mastitis
Extrapulmonary tuberculosis
Presumptive tuberculous mastitis
==== Body
pmcINTRODUCTION

One third of the world's population has had contact with Mycobacterium tuberculosis, which causes tuberculosis (TB). TB is more common in developing countries, with 22 countries accounting for 80% of the affected individuals; Brazil ranks 16th in incidence. Tuberculous mastitis (TM) is a rare, but an important cause of breast infections that are difficult to diagnose 1 . The incidence of TM ranges from 0.1% in developed countries to approximately 4% in highly TB endemic countries 2 . In the Amazon, where TB is endemic, there has been only one TM report 3 . Patients with mastitis are usually treated with antibiotic therapy, and among those without resolution, TM should be differential. The sensitivity of tests for the diagnosis of TM is low (approximately 12% for M. tuberculosis culture, the gold standard technique), and the histological diagnosis is idiopathic granulomatous mastitis (IGM) 4 , 5 . Both have different treatments; however, many patients are treated with presumptive TM (P-TM). We present the clinical aspects and outcomes of 15 women with confirmed TM or P-TM-treated who showed a clinical response at Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, a reference service for infectious diseases in the Brazilian Amazon, located in Manaus, Amazonas, between 2013 and 2021. We defined antituberculosis therapeutic response as a diagnostic criterion.

Clinical, laboratory, and radiological data were obtained from the electronic medical records (iDoctor system). For the etiological diagnosis of TM, we consider the results of multiple procedures: fine needle aspiration; core needle biopsy (CNB); and laboratory tests, such as the purified protein derivative (PPD) skin test, Ziehl-Neelsen (ZN) staining, culturing, polymerase chain reaction, Xpert MTB RIF rapid molecular test (RMT), bacilloscopy (acid fast bacilli -AFB BAAR), histopathological evaluation, culture for identification of mycobacterium and aerobic bacteria, direct examination, and culture of fungi. For P-TM, the following were considered: (1) clinical mastitis, which is difficult to resolve with usual therapies; (2) PPD skin test positivity; (3) histology suggestive of IGM or nonspecific chronic mastitis; and (4) absence of recurrence during a minimum follow-up period of six months after treatment.

CASE REPORT

One hundred and twenty-four patients with IGM were identified throughout the study period: 5 and 10 were diagnosed with TM and P-TM, respectively. The clinical, laboratory, and radiological characteristics of the evaluated women are shown in Table 1. The average age among those diagnosed with TM was 35.4 (range: 22-50), while the average age among those with P-TM was 35.1 (range: 24-62). None of the patients were diagnosed with HIV; however, patients 1, 2, and 3 previously had TB. Most patients complained of pain, heat, breast erythema, breast lumps, and fistulous disease. Fever, chills, and axillary adenopathy were the most common systemic complaints. All patients had positive PPD (induration equal to or greater than 5 mm). Among the five patients with TM, only one had a bacteriologically confirmed positive culture. Altered mammography findings were nonspecific, and the ultrasound findings were highlighted. The ultrasonographic findings were more expressive. Six patients had abscesses and six had fistulas. The most common findings were fistulas, abscesses, circumscribed nodules, hypoechoic nodules, and skin thickening (Figures 1 and 2). Magnetic resonance imaging and chest computed tomography were performed for only one patient and no specific findings were observed. We grouped the individuals according to their diagnosis of TM and P-TM and found no differences between the groups, except for the follow-up and treatment time, which were shorter in the TM group, as expected (Supplementary Table 1), given the need for minimal follow-up and no recurrence.

TABLE 1: Clinical, laboratory, and radiological aspects per case.

ID	Mastitis classification	Age	Local symptoms	Systemic symptoms	Radiological aspects	Histology	Criteria	PPD (induration in mm)	Time of treatment (months)	Time of follow-up time (months)	Ultrasound	
1	TM	22	Pain, erythema, papillary discharge, nodule/mass, and fistula	Fever and chills, axillary lymph nodes	Abscess and fistula	NP	AFB positive in respiratory sample	NP	6.2	8.08	Sclerosant	
2	TM	41	Pain, erythema, papillary discharge, and nodule/mass	Fever and chills	Circumscribed hypoechoic nodule	ICM (ZN+)	AFB positive in respiratory sample	NP	8.8	1.66	Nodular	
3	TM	24	Pain, erythema, papillary discharge, nodule/mass, and fistula	Axillary adenopathy	Abscess and fistula	GCMc	PPD, lung TB and GCM	13	6.0	4.39	Nodular	
4	TM	50	Pain, erythema, papillary discharge, and abscess	Fever and chills	Hypoechoic nodule	GCMc (ZN+)	PPD, Biopsy	8	6.0	0.01	Nodular	
5	TM	40	Pain, erythema, papillary discharge, nodule/mass, and abscess	Axillary adenopathy	Circumscribed hypoechoic nodule	ICM	Positive culture	NP	9.0	3,89	NP	
6	P-TM	39	Erythema, papillary discharge, and nodule/mass	Fever and chills, axillary adenopathy	Abscess, irregular hypoechoic nodule, architectural distortion	GCM	PPD and GCM	25	8.0	24.17	Nodular	
7	P-TM	62	Pain, erythema, nodule/mass, and abscess	Axillary adenopathy	Fistula and skin thickening	ICM	PPD	21	9.3	9.91	Diffuse	
8	P-TM	26	Pain, erythema, nodule/mass, and abscess	Fever and chills	Circumscribed hypoechoic nodule and axillary adenopathy.	GCM	PPD and GCM	12	6.0	6.66	Nodular	
9	P-TM	41	Pain, erythema, nodule/mass, and fistula	Fever and chills	Fistula	GCMc	PPD, GCM, IGRA	25	6.0	14.1	Sclerosant	
10	P-TM	29	Pain, erythema, nodule/mass, and fistula	-	Abscess	GCM	PPD and GCM	14	9.0	15.11	Nodular	
11	P-TM	34	Pain, erythema nodule/mass, and fistula	Fever and chills, axillary adenopathy	Confluent nodules	ICM	PPD	19	9.1	18.47	Nodular	
12	P-TM	33	Pain, erythema, and papillary discharge		Abscess and axillary adenopathy	ICM	PPD	18	8.3	6.01	Diffuse	
13	P-TM	24	Pain, erythema, papillary discharge, abscess and fistula	Fever and chills	Abscess and axillary adenopathy	ICM	PPD	17	9.0	6.03	Sclerosant	
14	P-TM	29	Pain, erythema, papillary discharge, abscess and fistula	-	Fistula	ICM	PPD and CT	15	10.1	8.78	Diffuse	
15	P-TM	34	Pain, erythema, and fistula	-	Fistula	GCM	PPD and GCM	5	7.1	26.06	Nodular	
AFB: acid-fast bacilli; IGRA: interferon gamma release assay; TM: tuberculous mastitis; P-TM: presumable-tuberculous mastitis; GCMc: caseous granulomatous chronic mastitis; GCM: granulomatous chronic mastitis; ICM: non-specific chronic mastitis; CT: computed tomography; NP: not performed; PPD: purified protein derivative; ZN: Ziehl-Neelsen stain; TB: Tuberculosis. Lung TB was diagnosed by lung biopsy.

FIGURE 1: Patient with a presumed diagnosis of breast tuberculosis. a) Breast ultrasound showing a solid hypoechoic nodule with circumscribed margins in the left breast. b) Left breast showing abscesses, scars, and fistulas in the sixth week of treatment for breast tuberculosis. c) Left breast showing abscesses, scars, and fistulas on the third month of treatment for breast tuberculosis. d) Left breast showing clinical improvement 10 months after starting treatment.

FIGURE 2: Patients in the third month of treatment for bilateral mammary and lymph node tuberculosis. a) and b) Images of the breast and axillary regions with scars, fistulas, erythema, and skin thickening. c) Breast ultrasonography demonstrating a fistulous path with a collection of thick fluid intermingled in the inferolateral quadrant of the right breast. d) Breast ultrasound showing skin thickening in the left axillary region.

DISCUSSION

TB is common in underdeveloped and developing countries, such as Africa, India, and Pakistan 4 . In Brazil, TB is endemic to the Amazon, with an estimate is 74.1 per 100,000 inhabitants. In Manaus, the rate is 93.2 per 100,000 inhabitants and is associated with income inequalities that influence health and TB transmission 6 . Although TB is a common disease in the Amazon region, we found 4% TM and 8% P-TM cases in women treated with idiopathic granulomatous mastitis at a reference hospital for infectious diseases in the Brazilian Amazon. The low frequency of TM can be explained by the diagnostic difficulty, which is generally defined as IGM. The importance of the diagnostic definition is that the treatment differs, since IGM is usually treated with surgery or immunosuppressive drugs, such as corticosteroids and methotrexate, which are harmful if the patient has TM. In addition, it is harmful to the patient undergoing a surgical procedure when there is a treatable etiology of a disease that may be recurrent; therefore, the etiology must be extensively evaluated. However, IGM is treated with immunosuppressants and has a high recurrence rate 7 . One treatment option for IGM is surgery, including mastectomy. The problem is performing surgery when there is a treatable etiology; therefore, the etiology must be evaluated extensively.

In the present study, the diagnostic method varied according to the medical criteria. However, we adjusted the definitions and re-evaluated the classification of cases. According to medical records, 23 women had TM or P-TM; however, based on a detailed analysis of the kinetics, diagnostic methods used, clinical characteristics, and response to therapy, we found only 15 cases. Diagnostic evaluation is essential, and many of these patients are treated with antibiotic therapy and have persistent or recurrent breast findings 4 . Patients should be evaluated histologically in the absence of resolution. In the presence of granulomatous lesions, IGM, TM should be considered as differential diagnosis 8 . The gold standard for the diagnosis of the disease is the detection of the etiologic agent, M. tuberculosis using Ziehl-Neelsen staining or culture. However, AFB smear positivity and ZN staining are not frequently performed. In most cases, breast TB can only be accurately diagnosed using the histological identification of a typical necrotizing granulomatous lesion 9 . On biopsy, the predominance of neutrophils in the background and relative absence of caseous necrosis favor the diagnosis of granulomatous mastitis. Generally, CNB is sufficient for evaluation, therefore, an open biopsy is rarely necessary 10 . In TB-endemic areas, the PPD skin test may be positive and related to previous exposure to M. tuberculosis in those vaccinated with the Bacillus Calmette-Guerin vaccine or previous exposure to nontuberculous mycobacteria. It is difficult to distinguish between an old and recent infection; therefore, the PPD skin test lacks diagnostic value 11 . In our study, almost all patients treated for TM showed elevated skin test results.

The Brazilian study included 20 cases, of which 19 women had IGM with caseous necrosis and the ZN test was positive in only one patient. All the patients had high PPD levels. The patients were treated for six months, with a mean follow-up of 12 months (8-14 months), and no recurrence was observed 12 . Despite having 15 patients (five with TM and 10 with P-TM), our study constitutes one of the largest Brazilian studies influenced by the endemic area and treatment in specific treatment centers. PPD values and follow-up times were similar.

This study had some limitations, particularly those associated with the study design. However, it represents the second largest sample in Brazil and originates from an endemic region. The lack of positivity criteria for all patients was overcome by the response to therapy and the six-month follow-up of patients with P-TM. This study aimed to establish the criteria based on the presence of a therapeutic response.

In conclusion, standardizing diagnostic tests can increase the positivity rate for TM. P-TM must be considered based on clinical and radiological suspicion, associating presumptive pathological data with examinations that indirectly suggest exposure to TB. Among the treated patients, the anti-TB therapeutic response must be considered, and one of the criteria for the final diagnosis is the response to long-term therapy.

ACKNOWLEDGMENTS

We offer our thanks to the Universidade Federal do Amazonas, Universidade Estadual Paulista and Fundação de Medicina Tropical Doutor Heitor Vieira Dourado for their provision of technical support necessary for the development and implementation of this study.

Financial Support: This study received no financial support.
==== Refs
REFERENCES

1 Ramaema DP Buccimazza I Hift RJ Prevalence of breast Tuberculosis: retrospective analysis of 65 patients attending a tertiary hospital in Durban, South Africa S Afr Med J 2015 105 10 866 869 26428595
2 Sabageh D Amao EA Ayo-Aderibigbe AA Sabageh AO Tuberculous mastitis simulating carcinoma of the breast in a young Nigerian woman: a case report Pan Afr Med J 2015 21 125 125 10.11604/pamj.2015.21.125.6336 26327962
3 Bianco SR Gurgel RL Tavares MA Radiological aspects of primary Tuberculosis in the breast: a case report and review of the literature Rev Soc Bras Med Trop 2005 42 2 203 205
4 Grover H Grover SB Goyal P Hegde R Gupta S Malhotra S Clinical and imaging features of Idiopathic Granulomatous Mastitis - The diagnostic challenges and a brief review Clin Imaging 2021 69 126 132 32717540
5 Gupta PP Gupta KB Yadav RK Agarvval D Tuberculous mastitis: A review of seven consecutive cases Ind J Tub 2003 50 1 47 50
6 Teixeira R Rodrigues MGA Ferreira MD Borges MC Safe I Melo GC Tuberculosis and malaria walk side by side in the brazilian Amazon: an ecological approach Trop Med Int Health 2019 24 8 1003 1010 31233671
7 Mohammed S Statz A Lacross JS Lassinger BK Contreras A Gutierrez C Granulomatous Mastitis: a 10 year experience from a large inner city county hospital J Surg Res 2013 184 1 299 303 23890401
8 Maione C Palumbo VD Maffongelli A Damiano G Buscemi S Spinelli G al et Diagnostic techniques and multidisciplinary approach in Idiopathic Granulomatous Mastitis: a revision of the literature Acta Biomed 2019 90 1 11 15
9 Fatima K Naz F Tuberculosis of male breast: a rare benign entity Cureus 2019 11 5 e4709 31355069
10 Sripathi S Ayachit A Bala A Kadavigere R Kumar S Idiopathic Granulomatous Mastitis: a diagnostic dilemma for the breast radiologist Insights Imaging 2016 7 4 523 529 27164916
11 Fernandez Arias A Mantoux versus immunoferon-gamma test for diagnosis of latent Tuberculosis infection in TB patient contacts Aten Primaria 2011 43 1 18 25 20381206
12 Silva BB Costa PVL Pires CG Pereira JD Filho Santos AR Tuberculosis of the breast: analysis of 20 cases and a literature review Trans R Soc Trop Med Hyg 2009 103 6 559 556 19269000
